Olivia Dean

9 November 2021

Director of IMPACT’s TRIALS group, Dr Olivia Dean leads a novel therapies program, with experience in developing and coordinating several successful multi-centre national and international randomised controlled trials in mental health. In addition to her role directing current clinical trials, Olivia has broad research interests including anti-inflammatory treatments for depression, oxidative biology and autism, mitochondrial dysfunction in bipolar disorder, and molecular markers of psychiatric illness.

Research interests

Affective and anxiety disorders

CREDIT Researchers feature in Magda’s Big National Health Check

Professor Pat McGorry (Orygen) and Alfred Deakin Professor Felice Jacka

Current research into new treatments for bipolar depression

A team including CREDIT CRE researchers have recently published a

Impact of ultra-processed foods on the brain

Listen to the fascinating conversation that Alfred Deakin Professor Felice

IMPACT researchers named on Highly Cited Researchers list

Nine Deakin University academics have been named among the world’s most influential researchers in their fields following the release of the 2023 Clarivate™ Highly Cited Researchers™ list. Four of the members are researchers at IMPACT. A Highly Cited Researcher is an individual who has demonstrated significant and broad influence in their field(s) of research. Each […]

Find us

CREDIT CRE
Deakin University, 221 Burwood Highway, Burwood ,VIC, 3125

Get in touch

Email us impact@deakin.edu.au

Call us (+613) 5227 3762